http://rdf.ncbi.nlm.nih.gov/pubchem/patent/CN-105287498-A
Outgoing Links
| Predicate | Object |
|---|---|
| assignee | http://rdf.ncbi.nlm.nih.gov/pubchem/patentassignee/MD5_f9680f0eb74959416e90c37725afc92a |
| classificationIPCInventive | http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61K31-357 http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61P7-02 |
| filingDate | 2015-11-16-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
| inventor | http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_d7ef5637d0aa37a158093971512e5d11 |
| publicationDate | 2016-02-03-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
| publicationNumber | CN-105287498-A |
| titleOfInvention | Application of kendomycin C to prepare medicines resisting platelet aggregation |
| abstract | The invention relates to application of kendomycin C to prepare medicines resisting platelet aggregation. The related purpose of kendomycin C to prepare medicines resisting platelet aggregation is disclosed for the first time. Because the framework type belongs to a brand-new framework type and the activity of resisting platelet aggregation is unexpected, there is not the possibility that other compounds give any enlightenment, the technical scheme possesses prominent substantive features, and also application to resist platelet aggregation obviously possesses notable progress. |
| isCitedBy | http://rdf.ncbi.nlm.nih.gov/pubchem/patent/WO-2019227969-A1 |
| priorityDate | 2015-11-16-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
| type | http://data.epo.org/linked-data/def/patent/Publication |
Incoming Links
Total number of triples: 20.